Inhibrx Biosciences (INBX) Change in Account Payables (2023 - 2025)
Inhibrx Biosciences (INBX) reported Change in Account Payables of -$829000.0 for Q4 2025, up 73.42% year-over-year from -$478027.5 in Q4 2024, and up 45.42% quarter-over-quarter from -$1.5 million in Q3 2025.
Inhibrx Biosciences (INBX) Change in Account Payables (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Change in Account Payables data on file, last reported at -$829000.0 in Q4 2025.
- Change in Account Payables for Q4 2025 came in at -$829000.0, up 73.42% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.3 million (down 118.44% YoY), and the FY2025 annual result was -$3.3 million, down 118.44% from the prior year.
- Change in Account Payables improved to -$829000.0 in Q4 2025 per INBX's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $17.4 million in Q2 2024 and troughed at -$3.1 million in Q4 2024.
- A 3-year average of $1.6 million and a median of -$525000.0 in 2024 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 73.42% in 2025 and fell as far as 237.56% in 2025.
- A 3-year view of Change in Account Payables shows it stood at $2.9 million in 2023, then tumbled by 207.18% to -$3.1 million in 2024, then soared by 73.42% to -$829000.0 in 2025.
- Business Quant data shows INBX's Change in Account Payables at -$829000.0 in Q4 2025, -$1.5 million in Q3 2025, and -$600000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | -829,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -829,000.00 |
| Dec 31, 2025 | -829,000.00 |
| Sep 30, 2025 | -1.52 Mn |
| Sep 30, 2025 | -1.52 Mn |
| Jun 30, 2025 | -600,000.00 |
| Jun 30, 2025 | -600,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Dec 31, 2024 | -3.12 Mn |
| Dec 31, 2024 | -3.12 Mn |
| Sep 30, 2024 | -450,000.00 |
| Sep 30, 2024 | -450,000.00 |
| Jun 30, 2024 | 17.42 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Sep 30, 2023 | -1.59 Mn |